nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—pancreatic cancer	0.476	1	CbGaD
Raltitrexed—TYMS—Gemcitabine—pancreatic cancer	0.209	0.539	CbGbCtD
Raltitrexed—TYMS—Fluorouracil—pancreatic cancer	0.179	0.461	CbGbCtD
Raltitrexed—FPGS—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00758	0.167	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.0038	0.0838	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00302	0.0665	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00276	0.0609	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	0.00231	0.0509	CbGpPWpGaD
Raltitrexed—TYMS—Pyrimidine metabolism—TYMP—pancreatic cancer	0.00179	0.0394	CbGpPWpGaD
Raltitrexed—Pemetrexed—SLC29A1—pancreatic cancer	0.00177	0.409	CrCbGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.00172	0.0379	CbGpPWpGaD
Raltitrexed—TYMS—Pyrimidine metabolism—DPYD—pancreatic cancer	0.00142	0.0313	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00139	0.0306	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.0011	0.0242	CbGpPWpGaD
Raltitrexed—TYMS—Paclitaxel—Docetaxel—pancreatic cancer	0.0011	0.451	CbGdCrCtD
Raltitrexed—TYMS—Gefitinib—Erlotinib—pancreatic cancer	0.00105	0.433	CbGdCrCtD
Raltitrexed—TYMS—E2F transcription factor network—RBBP8—pancreatic cancer	0.000919	0.0202	CbGpPWpGaD
Raltitrexed—Leucovorin—TYMS—pancreatic cancer	0.000787	0.182	CrCbGaD
Raltitrexed—Pralatrexate—TYMS—pancreatic cancer	0.000787	0.182	CrCbGaD
Raltitrexed—TYMS—Nucleotide metabolism—TYMP—pancreatic cancer	0.000697	0.0154	CbGpPWpGaD
Raltitrexed—Pemetrexed—TYMS—pancreatic cancer	0.000629	0.146	CrCbGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.00057	0.0126	CbGpPWpGaD
Raltitrexed—TYMS—Nucleotide metabolism—DPYD—pancreatic cancer	0.000552	0.0122	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000536	0.0118	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	0.000441	0.00972	CbGpPWpGaD
Raltitrexed—TYMS—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.000425	0.00936	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000389	0.00858	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—SYCP1—pancreatic cancer	0.00036	0.00793	CbGpPWpGaD
Raltitrexed—Methotrexate—TYMS—pancreatic cancer	0.000347	0.0804	CrCbGaD
Raltitrexed—TYMS—Azacitidine—Gemcitabine—pancreatic cancer	0.000285	0.117	CbGdCrCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000274	0.00604	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—PLAU—pancreatic cancer	0.000274	0.00603	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PRSS1—pancreatic cancer	0.000274	0.00603	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ZNRF3—pancreatic cancer	0.000274	0.00603	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—AHR—pancreatic cancer	0.00027	0.00595	CbGpPWpGaD
Raltitrexed—FPGS—Disease—DTX1—pancreatic cancer	0.000247	0.00545	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000246	0.00542	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000243	0.00535	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PRSS1—pancreatic cancer	0.000229	0.00505	CbGpPWpGaD
Raltitrexed—Alopecia—Irinotecan—pancreatic cancer	0.000228	0.00272	CcSEcCtD
Raltitrexed—Dyspepsia—Erlotinib—pancreatic cancer	0.000226	0.0027	CcSEcCtD
Raltitrexed—Decreased appetite—Tamoxifen—pancreatic cancer	0.000225	0.0027	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—RB1—pancreatic cancer	0.000225	0.00496	CbGpPWpGaD
Raltitrexed—Arrhythmia—Gemcitabine—pancreatic cancer	0.000224	0.00268	CcSEcCtD
Raltitrexed—Decreased appetite—Erlotinib—pancreatic cancer	0.000223	0.00267	CcSEcCtD
Raltitrexed—Oedema—Sunitinib—pancreatic cancer	0.000222	0.00266	CcSEcCtD
Raltitrexed—Pain—Tamoxifen—pancreatic cancer	0.000222	0.00265	CcSEcCtD
Raltitrexed—Constipation—Tamoxifen—pancreatic cancer	0.000222	0.00265	CcSEcCtD
Raltitrexed—Alopecia—Gemcitabine—pancreatic cancer	0.000222	0.00265	CcSEcCtD
Raltitrexed—Infection—Sunitinib—pancreatic cancer	0.000221	0.00264	CcSEcCtD
Raltitrexed—Arrhythmia—Fluorouracil—pancreatic cancer	0.00022	0.00264	CcSEcCtD
Raltitrexed—Constipation—Erlotinib—pancreatic cancer	0.000219	0.00262	CcSEcCtD
Raltitrexed—Pain—Erlotinib—pancreatic cancer	0.000219	0.00262	CcSEcCtD
Raltitrexed—Alopecia—Fluorouracil—pancreatic cancer	0.000218	0.00261	CcSEcCtD
Raltitrexed—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000217	0.0026	CcSEcCtD
Raltitrexed—Mouth ulceration—Epirubicin—pancreatic cancer	0.000216	0.00259	CcSEcCtD
Raltitrexed—Influenza like illness—Doxorubicin—pancreatic cancer	0.000215	0.00257	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000212	0.00468	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000212	0.00254	CcSEcCtD
Raltitrexed—Anorexia—Sunitinib—pancreatic cancer	0.000212	0.00253	CcSEcCtD
Raltitrexed—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000211	0.00253	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00021	0.00251	CcSEcCtD
Raltitrexed—Hypertonia—Epirubicin—pancreatic cancer	0.00021	0.00251	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000209	0.0046	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000208	0.00249	CcSEcCtD
Raltitrexed—Neutropenia—Docetaxel—pancreatic cancer	0.000208	0.00249	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000208	0.00458	CbGpPWpGaD
Raltitrexed—Sepsis—Epirubicin—pancreatic cancer	0.000208	0.00248	CcSEcCtD
Raltitrexed—FPGS—Disease—DTX4—pancreatic cancer	0.000207	0.00457	CbGpPWpGaD
Raltitrexed—Anaemia—Irinotecan—pancreatic cancer	0.000207	0.00248	CcSEcCtD
Raltitrexed—Abdominal pain—Tamoxifen—pancreatic cancer	0.000205	0.00245	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—EZH2—pancreatic cancer	0.000204	0.00449	CbGpPWpGaD
Raltitrexed—Body temperature increased—Erlotinib—pancreatic cancer	0.000203	0.00243	CcSEcCtD
Raltitrexed—Abdominal pain—Erlotinib—pancreatic cancer	0.000203	0.00243	CcSEcCtD
Raltitrexed—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000203	0.00242	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000202	0.00242	CcSEcCtD
Raltitrexed—Malaise—Irinotecan—pancreatic cancer	0.000202	0.00242	CcSEcCtD
Raltitrexed—Anaemia—Gemcitabine—pancreatic cancer	0.000202	0.00241	CcSEcCtD
Raltitrexed—FPGS—Disease—PPP2R5B—pancreatic cancer	0.000202	0.00444	CbGpPWpGaD
Raltitrexed—Weight decreased—Docetaxel—pancreatic cancer	0.000201	0.00241	CcSEcCtD
Raltitrexed—Leukopenia—Irinotecan—pancreatic cancer	0.000201	0.0024	CcSEcCtD
Raltitrexed—Mouth ulceration—Doxorubicin—pancreatic cancer	0.0002	0.00239	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ARG2—pancreatic cancer	0.000199	0.00438	CbGpPWpGaD
Raltitrexed—Anaemia—Fluorouracil—pancreatic cancer	0.000198	0.00237	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000198	0.00436	CbGpPWpGaD
Raltitrexed—Malaise—Gemcitabine—pancreatic cancer	0.000197	0.00236	CcSEcCtD
Raltitrexed—Cough—Irinotecan—pancreatic cancer	0.000196	0.00234	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000196	0.00431	CbGpPWpGaD
Raltitrexed—Dyspepsia—Sunitinib—pancreatic cancer	0.000196	0.00234	CcSEcCtD
Raltitrexed—Leukopenia—Gemcitabine—pancreatic cancer	0.000195	0.00234	CcSEcCtD
Raltitrexed—Renal failure—Docetaxel—pancreatic cancer	0.000195	0.00233	CcSEcCtD
Raltitrexed—FPGS—Disease—HEY2—pancreatic cancer	0.000194	0.00428	CbGpPWpGaD
Raltitrexed—Hypertonia—Doxorubicin—pancreatic cancer	0.000194	0.00232	CcSEcCtD
Raltitrexed—Stomatitis—Docetaxel—pancreatic cancer	0.000193	0.00231	CcSEcCtD
Raltitrexed—Hepatic failure—Epirubicin—pancreatic cancer	0.000193	0.00231	CcSEcCtD
Raltitrexed—Decreased appetite—Sunitinib—pancreatic cancer	0.000193	0.00231	CcSEcCtD
Raltitrexed—Conjunctivitis—Docetaxel—pancreatic cancer	0.000193	0.00231	CcSEcCtD
Raltitrexed—Leukopenia—Fluorouracil—pancreatic cancer	0.000192	0.0023	CcSEcCtD
Raltitrexed—Sepsis—Doxorubicin—pancreatic cancer	0.000192	0.0023	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000191	0.00229	CcSEcCtD
Raltitrexed—Cough—Gemcitabine—pancreatic cancer	0.000191	0.00228	CcSEcCtD
Raltitrexed—Constipation—Sunitinib—pancreatic cancer	0.00019	0.00227	CcSEcCtD
Raltitrexed—Pain—Sunitinib—pancreatic cancer	0.00019	0.00227	CcSEcCtD
Raltitrexed—Discomfort—Irinotecan—pancreatic cancer	0.000189	0.00226	CcSEcCtD
Raltitrexed—Asthenia—Tamoxifen—pancreatic cancer	0.000186	0.00223	CcSEcCtD
Raltitrexed—Arthralgia—Gemcitabine—pancreatic cancer	0.000186	0.00222	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—RBBP8—pancreatic cancer	0.000184	0.00406	CbGpPWpGaD
Raltitrexed—Asthenia—Erlotinib—pancreatic cancer	0.000184	0.0022	CcSEcCtD
Raltitrexed—Discomfort—Gemcitabine—pancreatic cancer	0.000184	0.0022	CcSEcCtD
Raltitrexed—Pruritus—Tamoxifen—pancreatic cancer	0.000183	0.00219	CcSEcCtD
Raltitrexed—Oedema—Irinotecan—pancreatic cancer	0.000183	0.00219	CcSEcCtD
Raltitrexed—Renal impairment—Epirubicin—pancreatic cancer	0.000182	0.00218	CcSEcCtD
Raltitrexed—Infection—Irinotecan—pancreatic cancer	0.000182	0.00217	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000182	0.00217	CcSEcCtD
Raltitrexed—Pruritus—Erlotinib—pancreatic cancer	0.000182	0.00217	CcSEcCtD
Raltitrexed—Discomfort—Fluorouracil—pancreatic cancer	0.000181	0.00216	CcSEcCtD
Raltitrexed—FPGS—Disease—HEY1—pancreatic cancer	0.00018	0.00396	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000179	0.00214	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000179	0.00394	CbGpPWpGaD
Raltitrexed—Hepatic failure—Doxorubicin—pancreatic cancer	0.000179	0.00214	CcSEcCtD
Raltitrexed—Oedema—Gemcitabine—pancreatic cancer	0.000178	0.00213	CcSEcCtD
Raltitrexed—Diarrhoea—Tamoxifen—pancreatic cancer	0.000177	0.00212	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000177	0.00212	CcSEcCtD
Raltitrexed—Infection—Gemcitabine—pancreatic cancer	0.000177	0.00212	CcSEcCtD
Raltitrexed—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000177	0.00212	CcSEcCtD
Raltitrexed—Abdominal pain—Sunitinib—pancreatic cancer	0.000176	0.0021	CcSEcCtD
Raltitrexed—Body temperature increased—Sunitinib—pancreatic cancer	0.000176	0.0021	CcSEcCtD
Raltitrexed—Diarrhoea—Erlotinib—pancreatic cancer	0.000176	0.0021	CcSEcCtD
Raltitrexed—Oedema—Fluorouracil—pancreatic cancer	0.000175	0.0021	CcSEcCtD
Raltitrexed—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000175	0.00209	CcSEcCtD
Raltitrexed—Anorexia—Irinotecan—pancreatic cancer	0.000174	0.00209	CcSEcCtD
Raltitrexed—Infection—Fluorouracil—pancreatic cancer	0.000174	0.00208	CcSEcCtD
Raltitrexed—FPGS—Metabolism—TYMP—pancreatic cancer	0.000174	0.00383	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000172	0.00206	CcSEcCtD
Raltitrexed—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000172	0.00205	CcSEcCtD
Raltitrexed—Anorexia—Gemcitabine—pancreatic cancer	0.00017	0.00203	CcSEcCtD
Raltitrexed—Renal impairment—Doxorubicin—pancreatic cancer	0.000169	0.00202	CcSEcCtD
Raltitrexed—Anorexia—Fluorouracil—pancreatic cancer	0.000167	0.002	CcSEcCtD
Raltitrexed—Vomiting—Tamoxifen—pancreatic cancer	0.000165	0.00197	CcSEcCtD
Raltitrexed—Rash—Tamoxifen—pancreatic cancer	0.000164	0.00196	CcSEcCtD
Raltitrexed—Dermatitis—Tamoxifen—pancreatic cancer	0.000163	0.00195	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—RB1—pancreatic cancer	0.000163	0.0036	CbGpPWpGaD
Raltitrexed—Vomiting—Erlotinib—pancreatic cancer	0.000163	0.00195	CcSEcCtD
Raltitrexed—Headache—Tamoxifen—pancreatic cancer	0.000162	0.00194	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000162	0.00194	CcSEcCtD
Raltitrexed—Rash—Erlotinib—pancreatic cancer	0.000162	0.00193	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000162	0.00356	CbGpPWpGaD
Raltitrexed—Dermatitis—Erlotinib—pancreatic cancer	0.000162	0.00193	CcSEcCtD
Raltitrexed—Dehydration—Epirubicin—pancreatic cancer	0.000161	0.00193	CcSEcCtD
Raltitrexed—Dyspepsia—Irinotecan—pancreatic cancer	0.000161	0.00193	CcSEcCtD
Raltitrexed—Headache—Erlotinib—pancreatic cancer	0.000161	0.00192	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.00016	0.00353	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00016	0.00191	CcSEcCtD
Raltitrexed—FPGS—Disease—JAG2—pancreatic cancer	0.000159	0.00351	CbGpPWpGaD
Raltitrexed—Asthenia—Sunitinib—pancreatic cancer	0.000159	0.00191	CcSEcCtD
Raltitrexed—Decreased appetite—Irinotecan—pancreatic cancer	0.000159	0.0019	CcSEcCtD
Raltitrexed—Arrhythmia—Docetaxel—pancreatic cancer	0.000159	0.0019	CcSEcCtD
Raltitrexed—Alopecia—Docetaxel—pancreatic cancer	0.000157	0.00188	CcSEcCtD
Raltitrexed—Pruritus—Sunitinib—pancreatic cancer	0.000157	0.00188	CcSEcCtD
Raltitrexed—FPGS—Disease—MEN1—pancreatic cancer	0.000157	0.00346	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000157	0.00345	CbGpPWpGaD
Raltitrexed—Constipation—Irinotecan—pancreatic cancer	0.000156	0.00187	CcSEcCtD
Raltitrexed—Pain—Irinotecan—pancreatic cancer	0.000156	0.00187	CcSEcCtD
Raltitrexed—FPGS—Disease—SLC2A2—pancreatic cancer	0.000156	0.00344	CbGpPWpGaD
Raltitrexed—Decreased appetite—Gemcitabine—pancreatic cancer	0.000155	0.00185	CcSEcCtD
Raltitrexed—Dyspepsia—Fluorouracil—pancreatic cancer	0.000154	0.00184	CcSEcCtD
Raltitrexed—Nausea—Tamoxifen—pancreatic cancer	0.000154	0.00184	CcSEcCtD
Raltitrexed—Constipation—Gemcitabine—pancreatic cancer	0.000152	0.00182	CcSEcCtD
Raltitrexed—Pain—Gemcitabine—pancreatic cancer	0.000152	0.00182	CcSEcCtD
Raltitrexed—Nausea—Erlotinib—pancreatic cancer	0.000152	0.00182	CcSEcCtD
Raltitrexed—Decreased appetite—Fluorouracil—pancreatic cancer	0.000152	0.00182	CcSEcCtD
Raltitrexed—Diarrhoea—Sunitinib—pancreatic cancer	0.000152	0.00182	CcSEcCtD
Raltitrexed—Dysgeusia—Docetaxel—pancreatic cancer	0.000152	0.00182	CcSEcCtD
Raltitrexed—Feeling abnormal—Irinotecan—pancreatic cancer	0.000151	0.0018	CcSEcCtD
Raltitrexed—FPGS—Disease—SHH—pancreatic cancer	0.00015	0.0033	CbGpPWpGaD
Raltitrexed—Pain—Fluorouracil—pancreatic cancer	0.00015	0.00179	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00015	0.00179	CcSEcCtD
Raltitrexed—Dehydration—Doxorubicin—pancreatic cancer	0.000149	0.00179	CcSEcCtD
Raltitrexed—FPGS—Disease—IAPP—pancreatic cancer	0.000148	0.00326	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000147	0.00176	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000145	0.0032	CbGpPWpGaD
Raltitrexed—Abdominal pain—Irinotecan—pancreatic cancer	0.000145	0.00173	CcSEcCtD
Raltitrexed—Body temperature increased—Irinotecan—pancreatic cancer	0.000145	0.00173	CcSEcCtD
Raltitrexed—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000144	0.00173	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—PPP2R5B—pancreatic cancer	0.000143	0.00316	CbGpPWpGaD
Raltitrexed—Anaemia—Docetaxel—pancreatic cancer	0.000143	0.00171	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000143	0.00315	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HSPA1B—pancreatic cancer	0.000142	0.00313	CbGpPWpGaD
Raltitrexed—Vomiting—Sunitinib—pancreatic cancer	0.000141	0.00169	CcSEcCtD
Raltitrexed—Body temperature increased—Gemcitabine—pancreatic cancer	0.000141	0.00169	CcSEcCtD
Raltitrexed—Neutropenia—Epirubicin—pancreatic cancer	0.00014	0.00168	CcSEcCtD
Raltitrexed—Rash—Sunitinib—pancreatic cancer	0.00014	0.00168	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GLP1R—pancreatic cancer	0.00014	0.00308	CbGpPWpGaD
Raltitrexed—Dermatitis—Sunitinib—pancreatic cancer	0.00014	0.00167	CcSEcCtD
Raltitrexed—Headache—Sunitinib—pancreatic cancer	0.000139	0.00166	CcSEcCtD
Raltitrexed—Leukopenia—Docetaxel—pancreatic cancer	0.000139	0.00166	CcSEcCtD
Raltitrexed—Body temperature increased—Fluorouracil—pancreatic cancer	0.000139	0.00166	CcSEcCtD
Raltitrexed—FPGS—Metabolism—DPYD—pancreatic cancer	0.000138	0.00303	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RB1—pancreatic cancer	0.000138	0.00303	CbGpPWpGaD
Raltitrexed—Weight decreased—Epirubicin—pancreatic cancer	0.000136	0.00162	CcSEcCtD
Raltitrexed—Cough—Docetaxel—pancreatic cancer	0.000135	0.00162	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—MYC—pancreatic cancer	0.000134	0.00295	CbGpPWpGaD
Raltitrexed—Arthralgia—Docetaxel—pancreatic cancer	0.000132	0.00158	CcSEcCtD
Raltitrexed—Nausea—Sunitinib—pancreatic cancer	0.000132	0.00158	CcSEcCtD
Raltitrexed—Renal failure—Epirubicin—pancreatic cancer	0.000131	0.00157	CcSEcCtD
Raltitrexed—Asthenia—Irinotecan—pancreatic cancer	0.000131	0.00157	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC2A2—pancreatic cancer	0.000131	0.00288	CbGpPWpGaD
Raltitrexed—Stomatitis—Epirubicin—pancreatic cancer	0.00013	0.00156	CcSEcCtD
Raltitrexed—Conjunctivitis—Epirubicin—pancreatic cancer	0.00013	0.00156	CcSEcCtD
Raltitrexed—Neutropenia—Doxorubicin—pancreatic cancer	0.00013	0.00155	CcSEcCtD
Raltitrexed—Sweating—Epirubicin—pancreatic cancer	0.000128	0.00153	CcSEcCtD
Raltitrexed—Asthenia—Gemcitabine—pancreatic cancer	0.000128	0.00153	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—FOXM1—pancreatic cancer	0.000128	0.00281	CbGpPWpGaD
Raltitrexed—FPGS—Disease—JAG1—pancreatic cancer	0.000127	0.0028	CbGpPWpGaD
Raltitrexed—Oedema—Docetaxel—pancreatic cancer	0.000126	0.00151	CcSEcCtD
Raltitrexed—Pruritus—Gemcitabine—pancreatic cancer	0.000126	0.00151	CcSEcCtD
Raltitrexed—Infection—Docetaxel—pancreatic cancer	0.000126	0.0015	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—pancreatic cancer	0.000126	0.0015	CcSEcCtD
Raltitrexed—Diarrhoea—Irinotecan—pancreatic cancer	0.000125	0.0015	CcSEcCtD
Raltitrexed—Pruritus—Fluorouracil—pancreatic cancer	0.000124	0.00148	CcSEcCtD
Raltitrexed—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000124	0.00148	CcSEcCtD
Raltitrexed—Diarrhoea—Gemcitabine—pancreatic cancer	0.000122	0.00146	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—pancreatic cancer	0.000122	0.00146	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	0.000121	0.00267	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD44—pancreatic cancer	0.000121	0.00266	CbGpPWpGaD
Raltitrexed—Stomatitis—Doxorubicin—pancreatic cancer	0.000121	0.00144	CcSEcCtD
Raltitrexed—Anorexia—Docetaxel—pancreatic cancer	0.000121	0.00144	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00012	0.00144	CcSEcCtD
Raltitrexed—FPGS—Disease—HSPA1A—pancreatic cancer	0.00012	0.00264	CbGpPWpGaD
Raltitrexed—Diarrhoea—Fluorouracil—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—pancreatic cancer	0.000119	0.00142	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000117	0.00257	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.000116	0.00257	CbGpPWpGaD
Raltitrexed—Vomiting—Irinotecan—pancreatic cancer	0.000116	0.00139	CcSEcCtD
Raltitrexed—Rash—Irinotecan—pancreatic cancer	0.000115	0.00138	CcSEcCtD
Raltitrexed—Dermatitis—Irinotecan—pancreatic cancer	0.000115	0.00138	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000115	0.00138	CcSEcCtD
Raltitrexed—Headache—Irinotecan—pancreatic cancer	0.000115	0.00137	CcSEcCtD
Raltitrexed—Vomiting—Gemcitabine—pancreatic cancer	0.000113	0.00136	CcSEcCtD
Raltitrexed—Rash—Gemcitabine—pancreatic cancer	0.000112	0.00134	CcSEcCtD
Raltitrexed—Dermatitis—Gemcitabine—pancreatic cancer	0.000112	0.00134	CcSEcCtD
Raltitrexed—Headache—Gemcitabine—pancreatic cancer	0.000112	0.00134	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000112	0.00246	CbGpPWpGaD
Raltitrexed—Vomiting—Fluorouracil—pancreatic cancer	0.000111	0.00133	CcSEcCtD
Raltitrexed—Dyspepsia—Docetaxel—pancreatic cancer	0.000111	0.00133	CcSEcCtD
Raltitrexed—Rash—Fluorouracil—pancreatic cancer	0.00011	0.00132	CcSEcCtD
Raltitrexed—Dermatitis—Fluorouracil—pancreatic cancer	0.00011	0.00132	CcSEcCtD
Raltitrexed—Decreased appetite—Docetaxel—pancreatic cancer	0.00011	0.00132	CcSEcCtD
Raltitrexed—Headache—Fluorouracil—pancreatic cancer	0.00011	0.00131	CcSEcCtD
Raltitrexed—Nausea—Irinotecan—pancreatic cancer	0.000109	0.0013	CcSEcCtD
Raltitrexed—Constipation—Docetaxel—pancreatic cancer	0.000108	0.00129	CcSEcCtD
Raltitrexed—Pain—Docetaxel—pancreatic cancer	0.000108	0.00129	CcSEcCtD
Raltitrexed—Arrhythmia—Epirubicin—pancreatic cancer	0.000107	0.00128	CcSEcCtD
Raltitrexed—Alopecia—Epirubicin—pancreatic cancer	0.000106	0.00127	CcSEcCtD
Raltitrexed—Nausea—Gemcitabine—pancreatic cancer	0.000106	0.00127	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—PPARG—pancreatic cancer	0.000105	0.0023	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Docetaxel—pancreatic cancer	0.000104	0.00125	CcSEcCtD
Raltitrexed—Nausea—Fluorouracil—pancreatic cancer	0.000104	0.00124	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000103	0.00124	CcSEcCtD
Raltitrexed—Dysgeusia—Epirubicin—pancreatic cancer	0.000102	0.00122	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	0.000102	0.00225	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CD44—pancreatic cancer	0.000101	0.00223	CbGpPWpGaD
Raltitrexed—Body temperature increased—Docetaxel—pancreatic cancer	0.0001	0.0012	CcSEcCtD
Raltitrexed—Abdominal pain—Docetaxel—pancreatic cancer	0.0001	0.0012	CcSEcCtD
Raltitrexed—Arrhythmia—Doxorubicin—pancreatic cancer	9.93e-05	0.00119	CcSEcCtD
Raltitrexed—Alopecia—Doxorubicin—pancreatic cancer	9.82e-05	0.00117	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—pancreatic cancer	9.73e-05	0.00214	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GCG—pancreatic cancer	9.7e-05	0.00214	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Epirubicin—pancreatic cancer	9.7e-05	0.00116	CcSEcCtD
Raltitrexed—Anaemia—Epirubicin—pancreatic cancer	9.66e-05	0.00116	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	9.57e-05	0.00211	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SMAD4—pancreatic cancer	9.54e-05	0.0021	CbGpPWpGaD
Raltitrexed—Dysgeusia—Doxorubicin—pancreatic cancer	9.47e-05	0.00113	CcSEcCtD
Raltitrexed—Malaise—Epirubicin—pancreatic cancer	9.43e-05	0.00113	CcSEcCtD
Raltitrexed—Leukopenia—Epirubicin—pancreatic cancer	9.36e-05	0.00112	CcSEcCtD
Raltitrexed—FPGS—Disease—HES1—pancreatic cancer	9.31e-05	0.00205	CbGpPWpGaD
Raltitrexed—Cough—Epirubicin—pancreatic cancer	9.12e-05	0.00109	CcSEcCtD
Raltitrexed—FPGS—Metabolism—STK11—pancreatic cancer	9.12e-05	0.00201	CbGpPWpGaD
Raltitrexed—Asthenia—Docetaxel—pancreatic cancer	9.08e-05	0.00109	CcSEcCtD
Raltitrexed—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.97e-05	0.00107	CcSEcCtD
Raltitrexed—Pruritus—Docetaxel—pancreatic cancer	8.95e-05	0.00107	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—pancreatic cancer	8.94e-05	0.00107	CcSEcCtD
Raltitrexed—Arthralgia—Epirubicin—pancreatic cancer	8.9e-05	0.00106	CcSEcCtD
Raltitrexed—Discomfort—Epirubicin—pancreatic cancer	8.79e-05	0.00105	CcSEcCtD
Raltitrexed—Malaise—Doxorubicin—pancreatic cancer	8.72e-05	0.00104	CcSEcCtD
Raltitrexed—Leukopenia—Doxorubicin—pancreatic cancer	8.66e-05	0.00104	CcSEcCtD
Raltitrexed—Diarrhoea—Docetaxel—pancreatic cancer	8.65e-05	0.00104	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	8.57e-05	0.00189	CbGpPWpGaD
Raltitrexed—Oedema—Epirubicin—pancreatic cancer	8.53e-05	0.00102	CcSEcCtD
Raltitrexed—Infection—Epirubicin—pancreatic cancer	8.48e-05	0.00101	CcSEcCtD
Raltitrexed—Cough—Doxorubicin—pancreatic cancer	8.44e-05	0.00101	CcSEcCtD
Raltitrexed—Thrombocytopenia—Epirubicin—pancreatic cancer	8.35e-05	0.000999	CcSEcCtD
Raltitrexed—TYMS—Metabolism—PRSS1—pancreatic cancer	8.35e-05	0.00184	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Epirubicin—pancreatic cancer	8.25e-05	0.000986	CcSEcCtD
Raltitrexed—Arthralgia—Doxorubicin—pancreatic cancer	8.23e-05	0.000985	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—pancreatic cancer	8.2e-05	0.00181	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—pancreatic cancer	8.16e-05	0.0018	CbGpPWpGaD
Raltitrexed—Discomfort—Doxorubicin—pancreatic cancer	8.14e-05	0.000973	CcSEcCtD
Raltitrexed—Anorexia—Epirubicin—pancreatic cancer	8.13e-05	0.000973	CcSEcCtD
Raltitrexed—Vomiting—Docetaxel—pancreatic cancer	8.04e-05	0.000962	CcSEcCtD
Raltitrexed—Rash—Docetaxel—pancreatic cancer	7.98e-05	0.000954	CcSEcCtD
Raltitrexed—Dermatitis—Docetaxel—pancreatic cancer	7.97e-05	0.000953	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	7.95e-05	0.00175	CbGpPWpGaD
Raltitrexed—Headache—Docetaxel—pancreatic cancer	7.92e-05	0.000948	CcSEcCtD
Raltitrexed—Oedema—Doxorubicin—pancreatic cancer	7.89e-05	0.000944	CcSEcCtD
Raltitrexed—FPGS—Metabolism—TYMS—pancreatic cancer	7.84e-05	0.00173	CbGpPWpGaD
Raltitrexed—Infection—Doxorubicin—pancreatic cancer	7.84e-05	0.000938	CcSEcCtD
Raltitrexed—FPGS—Disease—HIF1A—pancreatic cancer	7.8e-05	0.00172	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TSC2—pancreatic cancer	7.78e-05	0.00172	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.77e-05	0.00093	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	7.74e-05	0.00171	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.73e-05	0.000924	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	7.67e-05	0.00169	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.63e-05	0.000913	CcSEcCtD
Raltitrexed—FPGS—Disease—APOE—pancreatic cancer	7.62e-05	0.00168	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—pancreatic cancer	7.52e-05	0.0009	CcSEcCtD
Raltitrexed—Nausea—Docetaxel—pancreatic cancer	7.51e-05	0.000899	CcSEcCtD
Raltitrexed—Dyspepsia—Epirubicin—pancreatic cancer	7.51e-05	0.000898	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	7.47e-05	0.00165	CbGpPWpGaD
Raltitrexed—Decreased appetite—Epirubicin—pancreatic cancer	7.42e-05	0.000887	CcSEcCtD
Raltitrexed—Constipation—Epirubicin—pancreatic cancer	7.3e-05	0.000873	CcSEcCtD
Raltitrexed—Pain—Epirubicin—pancreatic cancer	7.3e-05	0.000873	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ARG2—pancreatic cancer	7.24e-05	0.0016	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.19e-05	0.00086	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—pancreatic cancer	7.17e-05	0.00158	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NOTCH1—pancreatic cancer	7.03e-05	0.00155	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Epirubicin—pancreatic cancer	7.03e-05	0.000841	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—BRCA2—pancreatic cancer	7e-05	0.00154	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.98e-05	0.000834	CcSEcCtD
Raltitrexed—Dyspepsia—Doxorubicin—pancreatic cancer	6.95e-05	0.000831	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.93e-05	0.00153	CbGpPWpGaD
Raltitrexed—Decreased appetite—Doxorubicin—pancreatic cancer	6.86e-05	0.000821	CcSEcCtD
Raltitrexed—FPGS—Disease—EGF—pancreatic cancer	6.8e-05	0.0015	CbGpPWpGaD
Raltitrexed—Constipation—Doxorubicin—pancreatic cancer	6.75e-05	0.000807	CcSEcCtD
Raltitrexed—Pain—Doxorubicin—pancreatic cancer	6.75e-05	0.000807	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	6.75e-05	0.00149	CbGpPWpGaD
Raltitrexed—Abdominal pain—Epirubicin—pancreatic cancer	6.74e-05	0.000807	CcSEcCtD
Raltitrexed—Body temperature increased—Epirubicin—pancreatic cancer	6.74e-05	0.000807	CcSEcCtD
Raltitrexed—Feeling abnormal—Doxorubicin—pancreatic cancer	6.51e-05	0.000778	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.46e-05	0.000772	CcSEcCtD
Raltitrexed—FPGS—Metabolism—APOE—pancreatic cancer	6.38e-05	0.00141	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TYMP—pancreatic cancer	6.33e-05	0.00139	CbGpPWpGaD
Raltitrexed—Abdominal pain—Doxorubicin—pancreatic cancer	6.24e-05	0.000746	CcSEcCtD
Raltitrexed—Body temperature increased—Doxorubicin—pancreatic cancer	6.24e-05	0.000746	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	6.21e-05	0.00137	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	6.19e-05	0.00137	CbGpPWpGaD
Raltitrexed—Asthenia—Epirubicin—pancreatic cancer	6.12e-05	0.000732	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	6.07e-05	0.00134	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CD—pancreatic cancer	6.04e-05	0.00133	CbGpPWpGaD
Raltitrexed—Pruritus—Epirubicin—pancreatic cancer	6.04e-05	0.000722	CcSEcCtD
Raltitrexed—Diarrhoea—Epirubicin—pancreatic cancer	5.84e-05	0.000698	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—TERT—pancreatic cancer	5.8e-05	0.00128	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.78e-05	0.00127	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CG—pancreatic cancer	5.76e-05	0.00127	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.74e-05	0.00126	CbGpPWpGaD
Raltitrexed—Asthenia—Doxorubicin—pancreatic cancer	5.66e-05	0.000677	CcSEcCtD
Raltitrexed—Pruritus—Doxorubicin—pancreatic cancer	5.58e-05	0.000668	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PPARG—pancreatic cancer	5.56e-05	0.00122	CbGpPWpGaD
Raltitrexed—Vomiting—Epirubicin—pancreatic cancer	5.42e-05	0.000649	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—pancreatic cancer	5.4e-05	0.000646	CcSEcCtD
Raltitrexed—Rash—Epirubicin—pancreatic cancer	5.38e-05	0.000643	CcSEcCtD
Raltitrexed—Dermatitis—Epirubicin—pancreatic cancer	5.37e-05	0.000643	CcSEcCtD
Raltitrexed—Headache—Epirubicin—pancreatic cancer	5.34e-05	0.000639	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.27e-05	0.00116	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CB—pancreatic cancer	5.27e-05	0.00116	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTGS2—pancreatic cancer	5.22e-05	0.00115	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GLP1R—pancreatic cancer	5.1e-05	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.1e-05	0.00112	CbGpPWpGaD
Raltitrexed—Nausea—Epirubicin—pancreatic cancer	5.07e-05	0.000606	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PIK3CD—pancreatic cancer	5.06e-05	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RB1—pancreatic cancer	5.05e-05	0.00111	CbGpPWpGaD
Raltitrexed—Vomiting—Doxorubicin—pancreatic cancer	5.02e-05	0.0006	CcSEcCtD
Raltitrexed—TYMS—Metabolism—DPYD—pancreatic cancer	5.02e-05	0.00111	CbGpPWpGaD
Raltitrexed—Rash—Doxorubicin—pancreatic cancer	4.98e-05	0.000595	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—pancreatic cancer	4.97e-05	0.000595	CcSEcCtD
Raltitrexed—Headache—Doxorubicin—pancreatic cancer	4.95e-05	0.000591	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—pancreatic cancer	4.9e-05	0.00108	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC2A2—pancreatic cancer	4.76e-05	0.00105	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—pancreatic cancer	4.69e-05	0.000561	CcSEcCtD
Raltitrexed—FPGS—Disease—CTNNB1—pancreatic cancer	4.67e-05	0.00103	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—pancreatic cancer	4.55e-05	0.001	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RB1—pancreatic cancer	4.51e-05	0.000994	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	4.44e-05	0.000978	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CB—pancreatic cancer	4.41e-05	0.000972	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—pancreatic cancer	4.37e-05	0.000963	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.31e-05	0.000949	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SRC—pancreatic cancer	4.22e-05	0.00093	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT3—pancreatic cancer	4.07e-05	0.000897	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—pancreatic cancer	4.06e-05	0.000895	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2A—pancreatic cancer	3.97e-05	0.000874	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—pancreatic cancer	3.81e-05	0.00084	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—pancreatic cancer	3.78e-05	0.000834	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—pancreatic cancer	3.77e-05	0.000832	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—pancreatic cancer	3.75e-05	0.000826	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—pancreatic cancer	3.7e-05	0.000815	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CD44—pancreatic cancer	3.69e-05	0.000813	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GCG—pancreatic cancer	3.54e-05	0.000779	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—pancreatic cancer	3.5e-05	0.00077	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—pancreatic cancer	3.35e-05	0.000739	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—STK11—pancreatic cancer	3.32e-05	0.000733	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—pancreatic cancer	3.21e-05	0.000708	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—pancreatic cancer	3.01e-05	0.000663	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—pancreatic cancer	2.97e-05	0.000655	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—pancreatic cancer	2.69e-05	0.000593	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—pancreatic cancer	2.69e-05	0.000592	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—pancreatic cancer	2.62e-05	0.000578	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—APOE—pancreatic cancer	2.33e-05	0.000513	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—pancreatic cancer	2.21e-05	0.000487	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—pancreatic cancer	2.2e-05	0.000484	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CG—pancreatic cancer	2.1e-05	0.000463	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPARG—pancreatic cancer	2.03e-05	0.000446	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CD—pancreatic cancer	1.85e-05	0.000407	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CB—pancreatic cancer	1.61e-05	0.000354	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—pancreatic cancer	1.59e-05	0.000351	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—pancreatic cancer	1.39e-05	0.000306	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—pancreatic cancer	9.8e-06	0.000216	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—pancreatic cancer	8.01e-06	0.000176	CbGpPWpGaD
